Log in Sign up
1 Matching Annotations
  1. Last 7 days
  2. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Liquid Chromatography-Tandem Mass Spectrometry Assay of Leukocyte Acid α-Glucosidase for Post-Newborn Screening Evaluation of Pompe Disease
    1
    1. ClingenBaseline 22 Oct 2026
      in Baseline Annotations
      LOPD-17

      CaseLOPD-17: 6 weeks diagnosis

      HPOsFreeText: GAA activity 6.5 (nmol · h−1 · mg−1), Mean percentage of normal 9.2%

      GenotypingMethod: Newborn Screening Panels


      Variant1: NM_000152.4:c.-32-13T>G

      ClinVar: 4027 http://www.ncbi.nlm.nih.gov/clinvar/variation/4027

      gnomAD: Ashkenazi Jewish 5.541e-3, Overall 3.401e-3 http://gnomad.broadinstitute.org/variant/17-78078341-T-G


      Variant2: NM_000152.4:c.1552-3C>G

      ClinVar: 419722 https://www.ncbi.nlm.nih.gov/clinvar/variation/419722/

      gnomAD: European (Non-Finnish) 2.713e-4, Overall 1.344e-4 http://gnomad.broadinstitute.org/variant/17-78084737-C-G


      CaseAddInfo: Late Onset Pompe Disease

      Individual CaseInfo Variant GenotypingMethod ClinVarID:4027 ClinVarID:419722 inferred_gene_hgnc:9588 inferred_gene_source:ClinVar GAA variant
    Visit annotations in context

    Tags

    • ClinVarID:4027
    • inferred_gene_hgnc:9588
    • inferred_gene_source:ClinVar
    • CaseInfo
    • Variant
    • ClinVarID:419722
    • GenotypingMethod
    • Individual
    • GAA variant

    Annotators

    • ClingenBaseline

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC5413112/
Share:
Group. Only group members will be able to view this annotation.
Only me. No one else will be able to view this annotation.
Hypothes.is
  • About
  • Blog
  • Bioscience
  • Education
  • Jobs
  • Help
  • Contact
  • Terms of Service
  • Privacy Policy